GlassScriptPhysician profile
Carol L Griffith
NPI 1780123562
$7,207.88
in general payments reported to CMS, 2019-2025
23 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,584 · 2022: $1,429 · 2023: $1,264 · 2024: $1,666 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,194.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,693.36 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $957.69 | 2021-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $891.98 | 2021-2025 | Farxiga, Wainua, Brilinta |
| Janssen Pharmaceuticals, INC | $735.22 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $608.18 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $511.23 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $337.65 | 2024-2025 | |
| Boston Scientific Corporation | $302.71 | 2023-2025 | Watchman Access System, Watchman Flx |
| Pfizer INC. | $299.80 | 2021-2025 | |
| Amarin Pharma, INC. | $291.90 | 2021-2022 | |
| Esperion Therapeutics, INC. | $136.97 | 2021-2025 | Nexletol |
| Novo Nordisk INC | $99.63 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $95.64 | 2022-2025 | Onpattro |
| Astellas Pharma US INC | $86.71 | 2021 | |
| Glaxosmithkline, LLC. | $24.25 | 2025 | Arexvy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.58 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lilly USA, LLC | $18.85 | 2025 | Zepbound |
| Cashflow Solutions, LLC | $18.58 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.91 | 2023 | Lifevest |
| Sanofi-Aventis U.S. LLC | $16.43 | 2021 | |
| Scpharmaceuticals INC. | $15.17 | 2024 | |
| Novartis Pharmaceuticals Corporation | $13.85 | 2021 | |
| Amryt Pharma Holdings LTD | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.